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Photoprotection for all: Current gaps
and opportunities
Darrell S. Rigel, MD, MS,a Henry W. Lim, MD,b Zoe D. Draelos, MD,c Teresa M. Weber, PhD,d and
Susan C. Taylor, MDe
New York, New York; Detroit, Michigan; High Point, North Carolina; Stamford, Connecticut; and
Philadelphia, Pennsylvania
The effects of solar radiation on human skin differ based on the skin phototype, presence or absence of
photodermatoses, biologic capacity to repair DNA damage, wavelength, intensity of sun exposure,
geographic latitude, and other factors, underscoring the need for a more tailored approach to
photoprotection. To date, the focus of photoprotection guidelines has been to prevent sunburn and
DNA damage induced by UV radiation, both UVB and UVA; however, several recent studies have shown
that visible light also generates reactive oxygen and nitrogen species that can contribute to skin damage
and pigmentation on the skin, particularly in people with skin of color. Therefore, individuals with dark
skin, while naturally better protected against UVB radiation by virtue of the high eumelanin content in
melanocytes, may need additional protection from visible light-induced skin damage. The current options
for photoprotection products need to expand, and potential strategies against visible light include the
addition of iron oxide, titanium dioxide, and biologically relevant antioxidants to sunscreen formulations as
well as supplementation with orally active antioxidants. ( J Am Acad Dermatol 2022;86:S18-26.)
Key words: photoprotection; skin of color; sunscreen; ultraviolet radiation; visible light.

INTRODUCTION
Sunlight provides heat and energy essential for
sustaining human life, but components of solar
radiation can have both acute and chronic adverse
effects on human skin. The adverse effects of solar
radiation on human skin have been attributed primarily to UV radiation (100-400 nm), specifically
UVB (290-320 nm), UVA2 (320-340 nm), and UVA1
(340-400 nm) radiation.1-3 UVB radiation is absorbed
primarily in the epidermis, where it induces the
inflammatory response of sunburn and directly
damages DNA.4,5 UVA, which makes up the majority
of UV radiation that reaches the earth’s surface,
penetrates into the dermis and can cause oxidative
damage and photoaging.6 UVA may also indirectly
cause DNA damage through the generation of
reactive oxygen species (ROS) that oxidize guanine
bases in DNA, leading to mutagenesis.4 Compared
with UV radiation, the impact of visible light (VL) on
human skin has received relatively little attention.

Recent studies have focused on the potential adverse
effects of VL (400-700 nm) and its role in pigmentary
disorders, especially in dark-skinned individuals (ie,
Fitzpatrick skin types [FSTs] IV-VI) (Fig 1).7,8
The effect of solar radiation on human skin is
clearly dependent on skin pigmentation (Fig 2). In
dark skin, the damage is limited to the upper layers
of the epidermis, whereas in individuals with light
skin, the damage occurs in the basal layers of the
epidermis as well. The upper epidermal layers in
dark skin have a higher melanin content and a higher
eumelanin/pheomelanin ratio than light skin.9
Because melanin, particularly eumelanin, acts as a
natural UVB filter, dark skin is better protected from
the damaging effects of UVB radiation. In addition,
DNA repair is more efficient in dark skin.10
UVA radiation and VL also appear to have
different effects based on skin tone, causing hyperpigmentation in individuals with skin of color (SOC)
skin (FST III-VI).7 Pigmentation induced by VL was
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shown to be darker and more sustained than
level, followed by sensitive skin formulation and
UVA1einduced pigmentation in individuals with
water/sweat resistance.15 Only 34% of consumers
7
FST III-VI. Moreover, the pigmentation effect is
considered broad-spectrum protection to be important in their purchasing decision.15 In a larger survey
potentiated when VL is combined with a small
11,12
percentage of UVA1.
assessing sunscreen knowledge, only 8.7% of the 334
consumers surveyed correctly understood the conThus, FSTs are affected by solar radiation in
cepts of SPF, broad-spectrum, and water resistance.16
different ways, underscoring the need for a
comprehensive and targeted
The American Academy of
approach to photoprotecDermatology guidelines do
CAPSULE SUMMARY
tion. The ‘‘photoprotection
not provide guidance on VL
for all’’ paradigm encomprotection. Because 50% of
Effects of ultraviolet radiation and visible
passes
the
American
sunlight reaching the surface
light on human skin depend on
Academy of Dermatology
of the earth is VL, it has been
pigmentation, with light skin more
guidance (see below) but
estimated that VL is responsusceptible to ultraviolet-induced skin
acknowledges that sunsible for 50% of free radicals
damage and dark skin to visible-light
screen protection requireinduced by sunlight.17 With a
einduced damage.
ments may vary among
greater understanding of the
individuals of different skin
effects of VL, future guideA personalized approach for
types. In individuals with fair
lines on photoprotection will
photoprotection requires a wider range
skin, the regular use of a
need to provide recommenof sunscreens, including formulations for
high-sun protection factor
dations for protecting skin
dark skin that protect against high(SPF), broad-spectrum sunfrom the damaging effects
energy visible light.
screen can help prevent UVof VL.
induced erythema and DNA
damage, reducing the risk of skin cancer and phoCurrent limitations in federal guidance on
toaging. Individuals with dark skin types may not
over-the-counter sunscreens
need high UVB protection but may require more
In February 2019, the US Food and Drug
protection from the pigment-inducing effects of VL.
Administration (FDA) issued a proposed rule to
Individuals of all skin phototypes require protection
provide updated guidance on establishing the safety
from the damaging effects of UVA/UVA1. The current
and efficacy of over-the-counter sunscreen products
armamentarium of sunscreens needs to expand to
(Table I).18 In May 2021, a proposed administrative
include products that protect against the effects of
order was issued.19 The FDA proposed several
UVA1 and VL for individuals with dark skin as well as
changes to the UVA protection and SPF labeling
products for individuals with photodermatoses,
requirements. Many of the currently marketed sunacne-prone skin, and other dermatologic needs.
screen products in the United States do not provide
balanced protection against UVB and UVA radiation
(ie, UVA protection factor of at least one third of the
CURRENT GAPS IN PHOTOPROTECTION
SPF, as recommended by the European guidelines).
UNDERSTANDING
A growing body of evidence demonstrates that
Current guidelines from the American Academy of
exposure to UVA, particularly UVA1, is linked to
Dermatology focus on protection from UVB and UVA
skin cancer and photoaging. To indicate adequate
radiation to prevent sunburn and reduce the risk of
UVA protection, the FDA currently allows sunscreens
skin cancer.13 They recommend (1) seeking shade
with SPF values of 15 or higher to be labeled as
when outdoors; (2) wearing sun-protective clothing;
‘‘broad spectrum’’ if a critical wavelength of 370 nm
and (3) using a broad-spectrum, water-resistant
or higher has been demonstrated.18 However, in an
sunscreen (SPF $30), reapplied every 2 hours or
13
evaluation of 20 US sunscreen products by the
after swimming or sweating.
critical wavelength method and the European
A recent survey of 540 US dermatologists
Union UVA standard (requiring a UVA protection
confirmed that physicians base their recommendafactor:SPF ratio of higher than 1:3), 19 of 20 tested
tions for sunscreen use primarily on the ability to
products met the critical wavelength standard, but
protect against UVB and UVA radiation (ie, SPF level
only 11 met the European Union standard, suggestand broad-spectrum protection).14
ing inferior UVA protection compared with sunUS consumer attitudes toward sunscreen use are
screen products in the European Union.20 In the
also focused primarily on protection from UV-related
new proposed guidelines, the FDA has suggested
effects. In a survey of 93 consumers, the main factor
that broad-spectrum products need to have a UVA1/
influencing the purchase of sunscreen was the SPF
d

d

S20 Rigel et al

Abbreviations used:
CPD:
FDA:
FST:
GA:
GRASE:
IL:
MMP:
ROS:
SPF:
TiO2:
VL:
ZnO:

cyclobutane pyrimidine dimer
US Food and Drug Administration
Fitzpatrick skin type
glycyrrhetinic acid
generally regarded as safe and effective
interleukin
matrix metalloproteinase
reactive oxygen species
sun protection factor
titanium dioxide
visible light
zinc oxide

UV ratio of 0.7 or higher, which would ensure more
uniform and balanced protection across the UVA1,
UVA2, and UVB ranges.

SOLAR RADIATION EFFECTS ON SKIN: UV
AND VL
UV-induced effects
UV radiation has been well established to have
acute and chronic effects on human skin. UVB
radiation penetrates into the epidermis and
induces a cascade of cytokines and vasoactive
mediators that results in the inflammatory response
known as sunburn.4 Both UVB and UVA cause DNA
damage in human keratinocytes that can lead to skin
cancer.
UVA radiation also damages DNA indirectly by
generating ROS, such as superoxide anion,
hydrogen peroxide, and hydroxyl radical. The nucleotides in DNA are highly susceptible to injury by
these ROS. The oxidation of nucleotide bases leads
to the mispairing of bases, resulting in mutagenesis.
For example, the oxidation of guanine results in a
modified nucleotide that tends to pair with adenine
rather than cytosine, mutating a guanine/cytosine
pair into an adenine/thymine.4
Natural DNA repair mechanisms exist to reverse
these mutagenic pathways, but if the UV exposure is
very high and the DNA damage is too great, the
repair mechanisms may fail; in this case, the defective cells may be eliminated via apoptosis or they
may acquire mutations that can then lead to skin
cancer.4 The ability to repair UV-induced DNA damage is more efficient in those with FST V-VI due, in
part, to the higher melanin content in the epidermis.
Individuals with FST I-II may be at higher risk for
‘‘dark’’ cyclobutane pyrimidine dimers (CPDs), DNA
lesions that are generated several hours after UVA
exposure, due to the higher pheomelanin content in
their skin.21 Antioxidants may help protect the skin
from DNA damage induced by UVB and UVA. For
example, vitamin E has been shown to inhibit light
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and dark CPDs as well as oxidative DNA damage in
keratinocytes.22
Glycyrrhetinic acid (GA) is a compound derived
from licorice root, with potent antioxidant and antiinflammatory properties.23 In cellular studies, GA
has been shown to prevent DNA fragmentation
induced by UVB radiation and significantly reduce
the generation of intracellular ROS in human keratinocytes irradiated with UVB. The antioxidant activity of GA increased as UVB intensity increased in a
dose-dependent manner.24 GA is also a potent
inhibitor of specific mammalian DNA polymerases
involved in DNA repair/recombination.25
Effects of VL
The effects of VL, particularly high-energy VL, on
human skin are not well understood. At high doses,
VL can cause erythema, with the intensity and
duration dependent on the skin type. Mahmoud
et al7 studied the effects of VL and UVA1 on immediate pigmentation and delayed tanning in volunteers with FST IV-VI and FST II. In the FST IV-VI
group, UVA1 induced pigmentation that was gray at
first, changed to brown with time, and faded rapidly
over 2 weeks, with no erythema observed at any
time. The lack of erythema was confirmed by the
spectroscopic assessment of oxyhemoglobin levels,
which found no dose-response or time-course relationship between UVA1 radiation and oxyhemoglobin level. Irradiation with VL induced immediate
pigmentation that was dark brown from the start and
surrounded by an ill-defined erythema that disappeared in less than 2 hours. The pigmentation was
sustained over the 2 weeks of the study and did not
fade.7 The intensity of the erythema increased with
higher doses of VL. In contrast, no pigmentation was
observed in individuals with FST II skin, even at
higher doses of visible light and UVA1 radiation. In a
subsequent study by Randhawa et al,26 multiple
exposures of VLinduced persistent pigmentation,
even in Caucasian skin explants.
VL-induced pigmentation also depends on the
wavelength, with blue-violet light (415 nmdpopularized in the lay press as ‘‘high-energy visible light’’)
associated with more hyperpigmentation than red
light (630 nm) and pigmentation lasting up to
3 months.27 Campiche et al28 found that blue light
(450 nm) induced erythema and hyperpigmentation
in FST III and IV skin. Unlike UV-induced hyperpigmentation, VL-induced pigmentation is mediated by
opsin-3.28 Blue light activates the opsin-3 receptor in
melanocytes, leading to increased calcium flux
and, eventually, an upregulation in melanogenesis.
The process involves the formation of tyrosinase/
tyrosinase-related protein complexes, leading to
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Fig 1. Electromagnetic radiation spectrum. RNS, Reactive nitrogen species; ROS, reactive
oxygen species. (adapted from Dupont et al5)

sustained tyrosinase activity in melanocytes of FST III
and higher. Tyrosinase activity did not change after
blue light irradiation in human melanocytes from
lightly pigmented (FST I-II) individuals but increased
in melanocytes from FST V and VI subjects. These
differences may explain why blue light induces
hyperpigmentation only in FST III and higher.29
VL has been shown to generate ROS in a dosedependent fashion following the photon-induced
activation of endogenous photosensitizers, with the
highest ROS levels observed after blue light irradiation.8,30 VL also induced the release of proinflammatory cytokines, including interleukin 1a (IL-1a), IL-1
receptor antagonist, IL-6, granulocyte colony-stimulating factor (GC-CSF), and IL-8, as well as increased
the expression of matrix metalloproteinase 1 (MMP1) and MMP-9.8 VL was found to activate the
epidermal growth factor receptor pathway in human

keratinocytes in a manner similar to UV radiation.
The epidermal growth factor receptor pathway has
been implicated in the activation of MMPs that can
accelerate skin aging.8

GAPS IN CURRENT PHOTOPROTECTION
PRODUCTS
Organic and inorganic UV filters
Currently available sunscreens in the United
States contain one or more FDA-approved UV filters
that protect against UVA, UVB, or both (Table II).
The 2019 FDA-proposed rule categorizes the
active photoprotective agents in current sunscreen
products into 3 groups: those generally regarded as
safe and effective (GRASE) (Category I), those not
GRASE (Category II), and those with insufficient
safety data to be classified as GRASE (Category III)
(Table I). In this proposed classification, titanium
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Fig 2. UV and VL protection factors according to skin phototype. SPF, Sun protection factor; PF,
protection factor; VL, visible light. (adapted from Passeron et al9)

Table I. Key components of the 2021 FDA-proposed administrative order on sunscreen
Topic

Balanced UVB/UVA
protection
SPF limit
Sunscreen
categorization

FDA-proposed rule

All sunscreens with SPF 15 or higher must satisfy broad-spectrum test requirements, with a UVA1/UV
ratio of 0.7 or higher
Maximum labeled SPF: 601
Maximum marketed SPF: 80
I (GRASE): TiO2, ZnO
II (non-GRASE): PABA, trolamine salicylate
III (insufficient evidence for GRASE categorization): cinoxate, dioxybenzone, ensulizole, homosalate,
meradimate, octinoxate, octisalate, octocrylene, padimate O, sulisobenzone, oxybenzone,
avobenzone

FDA, Food and Drug Administration; GRASE, generally regarded as safe and effective; PABA, para-aminobenzoic acid; SPF, sun protection
factor; TiO2, titanium dioxide; UV, ultraviolet; ZnO, zinc oxide.

dioxide (TiO2) and zinc oxide (ZnO) are classified as
Category I (GRASE), while para-aminobenzoic acid
and trolamine salicylate are considered Category II,
with the risks outweighing the benefits. It should be
noted that even before this proposed rule, the latter 2
were no longer being used in sunscreen products in
the United States. The remaining 12 active ingredients used in current over-the-counter sunscreens
have been classified as Category III.18
Sunscreen filters are classified as inorganic (also
known as physical or mineral) and organic (also
known as chemical).3 An inorganic filter act as a
semiconductive barrier against UV rays by absorbing
the radiation and, to a lesser extent, reflecting and
scattering the UV radiation.31,32 They are highly

effective immediately on application in preventing
UV-induced damage. Larger particles of inorganic
filters also scatter and absorb VL. The 2 available
inorganic filters, TiO2 and ZnO, provide protection
against both UVB and UVA2. Additionally, ZnO
provides protection against UVA1.33 TiO2 and ZnO
are essentially insoluble in water, preventing their
transdermal absorption and minimizing cutaneous
irritation.34 However, they leave a whitish, chalky
coat on the skin, which may be aesthetically unacceptable, particularly in individuals with dark skin.34
Formulation with TiO2 and ZnO nanoparticles can
help reduce the scattering and reflection in the
visible region of the spectrum, resulting in a transparent, more cosmetically acceptable form. But the
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Table II. FDA-approved sunscreen filters
Absorption range
UVB
(290320
nm)

Filter

Inorganic (mineral, physical)
Titanium dioxide
Zinc oxide
Organic (chemical)
p-Aminobenzoic acid
Avobenzone
Cinoxate
Dioxybenzone
Ecamsule*
Ensulizole
Homosalate
Meradimate
Octinoxate
Octisalate
Octocrylene
Oxybenzone
Padimate O
Sulisobenzone
Trolamine salicylate

x
x

UVA2
(320340
nm)

UVA1
(340400
nm)

x
x

x

x

x

x
x

x

x
x
x
x
x
x
x
x
x
x
x
x
x

x
x

FDA, Food and Drug Administration.
X indicates absorption range coverage.
*Ecamsule is approved only at specific concentrations in one
commercial line of products.

absorbance range decreases with particle size, and
nanoparticles of TiO2 and ZnO may provide less
protection in the UVA range and no protection in the
VL range.34
Organic filters act by absorbing UV radiation,
which is then emitted at higher wavelengths or
released as thermal energy.3 The majority of USapproved organic UV filters provide protection only
against UVB, and 3 provide broad-spectrum protection against both UVB and UVA2.33,35 Only avobenzone has been shown to protect against UVA1.35
Recent studies have shown that many organic UV
filters are readily absorbed through the skin, with
detectable plasma levels even days after use.36,37
Oxybenzone (benzophenone-3), which is present in
two thirds of sunscreens in the United States, is a
broad-spectrum UV filter that has significant transdermal absorption after topical use. This is of
concern because oxybenzone has been reported to
disrupt the endocrine system in humans and has
been linked to female infertility and low birth
weight; further study is needed to evaluate
the causality of this association.38-40 Significant transdermal penetration and detectable plasma levels
after maximal usage sunscreen application (ie, to
75% of body surface area, at 2 mg/cm2) have also

been demonstrated for avobenzone, octocrylene,
ecamsule, homosalate, octisalate, and octinoxate,
even after a single application.36,37 All 6 active
ingredients were detectable in plasma for up to
21 days.36 Again, additional study is necessary to
determine the clinical significance of these results.
Organic UV filters have also been reported to have
adverse impacts on marine life and water systems.
In laboratory settings, several organic UV filters,
including oxybenzone and octinoxate, have been
found to be toxic to coral reefs.41 However, it should
be noted that the concentrations to induce these
effects in the laboratory setting were 103- to 106-fold
higher than those observed in sea water in a real-life
setting.42
Ingredients for UV and VL protection
Tinted sunscreens, which contain, in addition to
UV filters, a blend of iron oxides and pigmentary
TiO2, protect against VL and UV while avoiding
the chalky white appearance of inorganic filters.43
These tinted sunscreens reduce VL transmission by
[90%.43 In a study comparing a nontinted mineral
sunscreen versus tinted products containing iron
oxides, the iron-oxideecontaining formulations
provided better protection against VL-induced
pigmentation in patients with FST IV.44 Iron oxides
may be black, red, or yellow; therefore, these
pigments, together with pigmentary TiO2, can be
mixed in different amounts to create tinted sunscreens to match a range of skin tones. Tinted
sunscreens containing iron oxides have been shown
to improve melasma lesions and melasma relapses
compared to a UV-only sunscreen.45 There remains a
need for nonpigmented ingredients that can protect
from VL to avoid the challenges of matching skin
tones and as an alternative for those who do not wish
to use pigmented products. The implementation of
validated standardized direct immunofluorescence
tests for measurements of the impact of VL on skin
would be beneficial in improving overall sunscreen
development.46
Antioxidants can scavenge ROS and may be
good candidates to incorporate into sunscreens.47
Polyphenols are naturally occurring antioxidants that
can be found in various plants. They have shown
photoprotective properties: inhibiting ROS and
ROS-mediated damage to DNA, upregulating DNA
repair enzymes, and inhibiting stress-response
cell signaling pathways.33,48 A combination of antioxidants, applied topically, can mitigate the effects of
VL, and the addition of a combination of natural
antioxidants (feverfew extract, soy extract, and
gamma-tocopherol) to a UVA/UVB sunscreen
reduced the effects of VL, decreasing ROS by 78%,
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IL-1a by 82%, and MMP-1 release by 87%.8 The
antioxidant combination alone also mitigated the
release of these mediators.8 Campiche et al28 reported that a topical formulation of niacinamide
(vitamin B3) plus a polyphenol-rich extract of the
green freshwater microalga Scenedesmus rubescens
reduced pigmentation after blue-light irradiation. A
sunscreen formulation containing a UVB/UVA filter
with licochalcone A, a potent antioxidant component of licorice extract, was found to protect against
VL-induced oxidative stress and prevent the bluelighteinduced degradation of carotenoids in the
stratum corneum.30
Other studies have examined the efficacy of
oral/systemic photoprotective agents. Polypodium
leucotomos is a tropical fern native to South
America whose extracts have antioxidant, antiinflammatory, and photoprotective properties. P.
leucotomos extracts are available as dietary supplements and have been shown to protect against
UVBeinduced changes, such as erythema, in subjects with FST I-III as well as against VL-induced
pigmentation in subjects with FST IV-VI.49
Mohammad et al50 reported a significant decrease
in persistent pigmentation after P. leucotomos
extract administration in 22 subjects with FST IVVI. Carotenoids, such as b-carotene, can quench
UV-induced ROS (eg, singlet molecular oxygen)
and may be used in conjunction with sunscreen as
photoprotection.51 In a meta-analysis of 7 studies,
dietary supplementation with b-carotene was
found to protect against sunburn, with the protective effect increasing with the duration of
supplementation.52
Currently available sunscreens focus on protecting the skin from UV-induced damage. Another
approach is to reverse or repair the UV-induced
damage after it has occurred, through the use of
absorbable DNA repair enzymes (eg, photolyase)
in topical sunscreens.53 Stege et al54 found that the
topical application of photolyase-containing liposomes reduced UVB radiationeinduced CPDs,
immunosuppressive effects, erythema, and sunburn cell formation. Further, as previously discussed, GA has been shown to have antioxidative
properties that prevent DNA fragmentation in human keratinocytes in vitro.24 In vivo, GA treatment
resulted in 50% fewer CPDs 24 hours after
UV irradiation compared to the vehicle-treated
control.55
Other photoprotective agents that have been
studied in populations susceptible to photodamage
include nicotinamide, which enhances DNA repair,
and afamelanotide, a melanocortin-1 receptor
agonist that promotes the synthesis of melanin.56
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SUMMARY AND CONCLUSION
The impact of VL on human skin is only beginning
to be understood. VL, at high doses, induces erythema and hyperpigmentation in subjects with dark
FSTs but not in those with light FSTs. VL has also
been found to generate reactive oxygen and nitrogen
species that may contribute to skin damage and
pigmentary disorders. Most of the currently available
sunscreen products are designed to protect against
UVB and UVA. Tinted sunscreens, which contain
iron oxide pigments, are currently the only photoprotection products available in the United States
that filter out VL. Other strategies being explored to
protect against VL-induced skin damage include the
addition of biologically relevant topical antioxidants
(eg, GA, polyphenols, licochalcone A) to sunscreen
formulations, supplementation with orally active
antioxidants (eg, P. leucotomos extract, b-carotene),
and the development of novel filters that absorb UV
radiation and reflect VL. With a greater understanding of the effects of solar radiation on different skin
types and the development of sunscreen products
that provide protection across the spectrum, from VL
to UV, ‘‘photoprotection for all’’ can become an
achievable reality in the near future.
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